Innovation

Georgia Fights for Healthcare Innovation: Lawsuit Filed Against Federal Government Over Delayed Implementation of Georgia Pathways Program

by

ATLANTA (AP) – Georgia has filed a lawsuit against the Centers for Medicare and Medicaid Services (CMS) in an effort to regain lost time for the implementation of the Georgia Pathways program. The state claims that CMS’s decision to rescind core elements of the program, despite a previously approved federal-state waiver, has unjustly delayed the expansion of Medicaid coverage to tens of thousands of low-income Georgians. The Georgia Pathways to Coverage initiative, a result of the bipartisan passage of Georgia’s Patients First Act in 2019, aimed to provide Medicaid coverage to previously ineligible individuals. The … Read more

Foreign Funding of Mass Tort Litigations Raises National Security Concerns and Threatens American Innovation

by

Washington, D.C. – Innovation is a critical asset for the United States, but it is facing a growing threat. Foreign competitors and adversaries are increasingly engaging in industrial espionage against American companies, posing a significant risk to national security. One emerging avenue through which foreign entities can gain access to sensitive information and manipulate the American economy is the third-party funding of mass tort litigation. To address this issue, a change in the law is necessary. Mass tort litigations involve lawsuits filed by lawyers who specialize in suing large corporations for damages caused by their … Read more

Holding the Third-Party Litigation Financing Industry Accountable: AdvaMed Urges Congressional Reform to Protect Patients and Innovation

by

Washington, D.C. – The U.S. House Oversight Committee held a hearing on September 13, 2023, to address the concerns surrounding third-party litigation financing. AdvaMed and its members have expressed significant worries about the impact of these financing practices. They argue that third-party speculators, along with the attorneys they fund, are taking advantage of the mass tort litigation system, prioritizing their own financial gain over the well-being of patients, medical device manufacturers, and the general public. By investing substantial amounts into advertising campaigns, these attorneys and financial backers can generate a large number of cases, many … Read more

Unmasking the Controversial Impact of Third-Party Litigation Funding on Public Health, Innovation, and Patients

by

NASHVILLE, Tennessee – Third party litigation funding (TPLF) has become an increasingly prevalent practice in the civil justice system, impacting various sectors, particularly medical technology manufacturers. However, concerns are being raised about the potential misuse of TPLF, arguing that it adversely affects public health, hampers innovation, and poses risks for patients. The use of TPLF has expanded significantly in recent years, contributing to the rise of mass tort litigation. Typically, this funding involves a third party providing financial assistance to claimants in exchange for a portion of any settlement or judgment in their favor. While … Read more